Skip to main content
CODEXIS, INC. logo

CODEXIS, INC. — Investor Relations & Filings

Ticker · CDXS ISIN · US1920051067 LEI · 549300KGLM6CDPTVSE20 US Professional, scientific and technical activities
Filings indexed 974 across all filing types
Latest filing 2026-04-14 Regulatory Filings
Country US United States of America
Listing US CDXS

About CODEXIS, INC.

https://www.codexis.com/

Codexis, Inc. is a protein engineering company that develops novel enzymes for therapeutic manufacturing and life science applications. Leveraging its proprietary CodeEvolver® technology platform, which integrates deep enzymology with machine learning, the company discovers and optimizes high-performance enzymes. Key applications include pharma biocatalysis for the sustainable synthesis of small molecule APIs and the ECO Synthesis® Manufacturing Platform for the efficient, scalable production of RNA therapeutics, such as siRNA. Codexis also provides custom-engineered enzymes for molecular biology and diagnostic applications, enabling faster and more precise processes for its partners in the pharmaceutical and life sciences sectors.

Recent filings

Filing Released Lang Actions
8-K - CODEXIS, INC. (0001200375) (Filer)
Regulatory Filings
2026-04-14 English
4 - CODEXIS, INC. (0001200375) (Filer)
Director's Dealing
2026-02-25 English
4 - CODEXIS, INC. (0001200375) (Filer)
Director's Dealing
2026-02-25 English
4 - CODEXIS, INC. (0001200375) (Filer)
Director's Dealing
2026-02-25 English
4 Filing
Director's Dealing
2026-02-09 English
4 Filing
Director's Dealing
2026-02-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.